Quay lại
Giá VISEN Pharmaceuticals (02561.HK)
Biểu đồ giá cổ phiếu 02561.HK
VISEN PHARMA-B (02561.HK)
VISEN Pharmaceuticals
HK$33.8
-1.51%
$-0.52
Thị trường đóng cửa: Jan 16, 16:00:00 HKT
Thống kê chính
Giá đóng cửa trước
$34.42
Giá mở cửa
$34.32
Phạm vi ngày
$33.1 - $34.32
Phạm vi 52 tuần
$29.06 - $69.15
Khối lượng
15.6K
Khối lượng trung bình
32.8K
EPS (TTM)
-2.12
Tỷ suất cổ tức
--
Vốn hóa thị trường
$3.8B
VISEN PHARMA-B là gì?
VISEN Pharmaceuticals operates as a biopharmaceutical company. The company is headquartered in Suzhou, Jiangsu and currently employs 54 full-time employees. The company went IPO on 2025-03-21. The firm's main products under development include lonapegsomatropin, navepegritide, and palopegteriparatide. The lonapegsomatropin is used to treat growth hormone deficiency in children aged 3 to 17 years old. The navepegritide is a disease repair therapy used to treat children with cartilage dysplasia aged 2 to 10 years old. The palopegteriparatide is a treatment method used to treat adult hypoparathyroidism. The firm is in the late stage of research and development, and its products are close to commercialization.
Đặc điểm
Chiến lược giao dịch
Tài nguyên
© 2025 Finture Development Limited. All rights reserved
